Carboxyl Ester Lipase Protects Against Metabolic Dysfunction-Associated Steatohepatitis by Binding to Fatty Acid Synthase

扫码查看

原文链接

万方数据
维普

外文摘要：Carboxyl ester lipase(CEL),a pivotal enzyme involved in lipid metabolism,is recurrently mutated in obese mice.Here,we aimed to elucidate the functional significance,molecular mechanism,and therapeu-tic potential of CEL in metabolic dysfunction-associated steatohepatitis(MASH).Hepatocyte-specific car-boxyl ester lipase gene(Cel)knockout(Cel△HEP)and wildtype(WT)littermates were fed with choline-deficient high-fat diet(CD-HFD)for 16 weeks,or methionine-and choline-deficient diet(MCD)for three weeks to induce MASH.Liquid chromatography-mass spectrometry and co-immunoprecipitation were employed to identify the downstream targets of CEL.CD-HFD/MCD-fed WT mice received intra-venous injections of CEL-adeno-associated viral,serotype 8(AAV8)to induce specific overexpression of CEL in the liver.We observed a decrease in CEL protein levels in MASH induced by CD-HFD or MCD in mice.Cel△HEP mice fed with CD-HFD or MCD exhibited pronounced hepatic steatosis,inflammation,lipid peroxidation,and liver injury compared to WT littermates,accompanied by increased hepatic nuclear factor kappa-light-chain-enhancer of activated B cell(NF-κB)activation.Consistently,Cel knockdown in mouse primary hepatocytes and AML12 cells aggravated lipid accumulation and inflammation,whereas CEL overexpression exerted the opposite effect.Mechanistically,CEL directly bound to fatty acid synthase(FASN),resulting in reduced FASN SUMOylation,which in turn promoted FASN degradation through the proteasome pathway.Furthermore,inhibition of FASN ameliorated hepatocyte lipid accumu-lation and inflammation induced by Cel knockdown in vivo and in vitro.Hepatocyte-specific CEL overex-pression using AAV8-Cel significantly mitigated steatohepatitis in mice fed with CD-HFD or MCD.CEL protects against steatohepatitis development by directly interacting with FASN and suppressing its expression for de novo lipogenesis.CEL overexpression confers a therapeutic benefit in steatohepatitis.

外文关键词：

Metabolic dysfunction-associated steatohepatitisCarboxyl ester lipaseFatty acid synthaseDe novo lipogenesisTreatment

作者：

Yang Song、Wei Zhong、Harry Cheuk-Hay Lau、Yating Zhang、Huayu Guan、Mingxu Xie、Suki Ha、Diwen Shou、Yongjian Zhou、Hongzhi Xu、Jun Yu、Xiang Zhang

展开 >

作者单位：

Department of Medicine and Therapeutics,Institute of Digestive Disease,State Key Laboratory of Digestive Disease,Li Ka Shing Institute of Health Sciences,The Chinese University of Hong Kong,Hong Kong 999077,China

Shenzhen Research Institute,The Chinese Unviersity of Hong Kong,Shenzhen 518057,China

Division of Gastroenterology and Hepatology,Renji Hospital,School of Medicine,Shanghai Jiao tong University,Shanghai 200025,China

Department of Gastroenterology and Hepatology,Guangzhou Digestive Disease Center,Guangzhou First People's Hospital,Guangzhou 510180,China

Department of Gastroenterology & Institute for Microbial Ecology &Xiamen Key Laboratory of Intestinal Microbiome and Human Health & Clinical Research Center for Gut Microbiota and Digestive Diseases of Fujian Province,Zhongshan Hospital of Xiamen University,School of Medicine,Xiamen University,Xiamen 361004,China

展开 >

基金：

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaInnovation and Technology Fund-Guangdong-Hong Kong Technology Cooperation Funding SchemeResearch Grants Council(RGC)Themebased Research SchemeResearch Grants Council-General Research FundResearch Grants Council-General Research FundHealth and Medical Research Fund,Hong KongHealth and Medical Research Fund,Hong KongCUHK Research Startup FundNatural Science Foundation of Fujian Province

项目编号：

822229018210335582272619GHP/086/21GDT12-703/19-R14117422141171230819133607210097FPU/2023/1492020J01122587

出版年：

2024

DOI：

10.1016/j.eng.2024.04.018

工程(英文)

CSTPCDEI

ISSN：2095-8099

年,卷(期)：2024.41(10)